Efficacy and biobehavioural basis of Baclofen in treatment of alcoholic liver disease

image - 800px %28%C2%B1%29 Baclofen Enantiomers Structural Formulae

This is a double-blind randomised placebo-controlled study investigating the efficacy of baclofen for the treatment of alcohol dependence in patients with alcoholic liver disease. Medications will be given for 12 weeks, with a further 6 months follow-up. Both male and female participants will be recruited to this study. Trial patients will be randomised to one of three treatment groups: (1) baclofen 30mg/day (10 mg t.i.d), (2) baclofen 75mg/day (25 mg t.i.d) or (3) Placebo (3 matched tabs/day).

Project Status
Ongoing Projects
Contact
image - K.Morley2
Research Fellow
Ph +612 9515 3636
Funding Body
National Health and Medical Research Council
Investigators
image - Paul Haber Sq
Chief Investigator
Ph +61 2 9515 6419
image - Andrew Baillie Sq
Chief Investigator
Ph +61 2 9850 9436
image - K.Morley2
Research Fellow
Ph +612 9515 3636
image - W. Logge Mac Uni
Research Assistant & PhD Candidate

Our Research Streams